Mirror Now
@mirrornow·2.2M subscribers·145K videos
DGCI To Review Applications For Full Market Approval Of Covaxin And Covishield Today
Posted
January 14, 2022
Views
2,181
Likes
15
Engagement
0.69%
January 14, 2022
2,181
15
0.69%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
3:48Now PlayingThe Drugs Controller General of India (DCGI) headed Subject Expert Committee will review applications of Bharat Biotech and SII for full market approval to Covaxin and Covishield today. The move comes after the Hyderabad-based vaccine manufacturer Bharat Biotech on Thursday announced that its indigenously developed Covid-19 vaccine Coavaxin is now a universal vaccine for adults and children. Earlier, Bharat Biotech, vaccine manufacturer had claimed that its Covid vaccine Covaxin can neutralise both Delta and Omicron variants of coronavirus. Meanwhile in a related development last month, the Drugs Controller General of India (DCGI) has granted emergency use authorisation to Bharat Biotech's Covaxin for children above 12 years with certain conditions.
SUBSCRIBE NOW for more such videos ►
For More Updates ►
Like us on Facebook ►
Follow us on Twitter ►
Follow us on Instagram ►
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
